CatalystWireBeta

UK small-cap RNS · 27 Oct 2025

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 07:33
    Half-year Results Results
    Unaudited interims for an early-stage explorer; no financial figures given in the text, the story is permit progress at Hussar (Environmental plan approved, final drill approval awaited) and funding via the August placing.
    Project milestones £1.0m · 4% of mcapoutlook positive +0.0% on the day
    Moved: Relist the enlarged company on the London Stock Exchange (first Q1 2024, later J: pending → delivered – The company was readmitted to the LSE main market on 30 July 2024 with a £5.0m raise. · Use the proceeds of placings to advance Hussar and Mt Winter work programmes: pending → on_track – Net proceeds of the August 2025 placing are earmarked for Hussar and Mt Winter work programmes and working capital. · Complete the 100% acquisition of Mt Winter and begin re-entry drilling by mid 20: pending → delayed – Mt Winter acquisition still awaits the draft ALRA agreement from the Central Land Council before the tenement is granted and settlement made.
  2. 07:00
    Results for the year ended 30 June 2025 Results
    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces its audited results for the year ended 30 June 2025.
    ahead of expectationsfirst since Oct 2023 −15.7% on the day
  3. 07:00
    Topline Results Significant in Steriwave ICU Study Results
    Steriwave Shows Significant Sustained ICU Pathogen Reduction in Royal Columbian Hospital Study Reinforcing Universal Nasal Decolonisation for Infection Control
    +4.0% on the day
  4. 07:00
    Half-year Results Results
    Truetide plc (AIM: TRUE), announces its interim results for the six months ended 30 September 2025.
    first since Oct 2023 +0.0% on the day
  5. 07:00
    3rd Quarter Results Results
    NAV per share rose 7.9% q-o-q to GEL 135.51, driven by private portfolio operating gains and the Lion Finance Group (LFG) share price, with buybacks adding to it. A one-off Imedi L litigation reserve took off 1.0 ppt.
    Capital return outlook positive +1.0% on the day
    Moved: new: GEL 700m capital return programme – Launched Aug 2025; US$ 26.3m bought back · new: Gormed hospital acquisition – Agreed 25 Oct 2025, pending regulatory approval · new: Imedi L legacy litigation – Appeal rejected; fully provided in 3Q25
  6. 07:00
    Final Audited Results Results
    Pre-revenue developer: loss narrowed to £2.93m from £3.90m and cash rose to £6.37m after the raise, but still no production and permitting milestones remain ahead.
    Project milestones £10.1m · 14% of mcapoutlook positivefirst since Oct 2023 +0.0% on the day
    Moved: new: Taronga permitting and development approval – EIS submitted September 2025 · new: Tellerhäuser fast-track permitting – LoMP submission being progressed
  7. 07:00
    Final Results and Publication of Annual Report Results
    · Gross margin improved to 40.7% (2024: 38.8%)
    +3.1% on the day
  8. 07:00
    Annual Report and Accounts and Notice of AGM Results
    The Report and Accounts for the year ended 30 June 2025 are now available on the Company's website at https://investors.altonare.com/.
    −14.9% on the day
  9. 07:00
    Final Results Results
    Final Results for the Year Ended 30 June 2025
    first since Oct 2023 +0.0% on the day
  10. 07:00
    Final Results Results
    Prelim FY2025 results show technical progress (MREP above 55% TREO) and strong backing, but the Phalaborwa DFS is now later than originally planned, pushing construction to 2027.
    Project milestones outlook positivefirst since Oct 2023 −13.2% on the day
    Moved: new: Phalaborwa DFS and financing – DFS delayed to 2026; construction targeted 2027 · new: Uberaba Economic Assessment – Economic Assessment underway · new: Phalaborwa separation route evaluation – Evaluation underway
  11. 07:00
    3rd Quarter Results Results
    AltynGold (LSE:ALTN), an established precious metals producer operating in Kazakhstan, is pleased to announce its production and operational update for the nine months to 30 September 2025 ("Q3 2025" or the "Period").
    in linefirst since Oct 2023 −4.0% on the day

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note